Aguilar Calvo Laboratory
Patricia Aguilar Calvo D.V.M, Ph.D., is an assistant professor of Neurology. Her lab studies the factors that modulate the interaction of misfolded proteins with glycoproteins and the impact in the pathogenesis of prion and Parkinson's diseases.
Arrant Laboratory
Andrew Arrant, Ph.D., is an Assistant Professor of Neurology. His laboratory is focused on the cellular mechanisms underlying Alzheimer's disease and frontotemporal dementia.
Cowell Laboratory
Rita Cowell, Ph.D., is a Professor of Neurology. Her laboratory is focused on identifying the mechanisms underlying cell death in Parkinson's Disease, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis using mouse models of disease.
De Miranda Laboratory
Briana De Miranda, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of environmental toxins in the pathogenesis of Parkinson disease.
Goldberg Laboratory
Matthew Goldberg, Ph.D., is an Associate Professor of Neurology. His laboratory is focused on identifying the mechanisms of neuronal degeneration in Parkinson's disease and investigating the roles of mitochondrial dysfunction, oxidative stress and genetic mutations in Parkin, DJ-1, PINK1, alpha-synuclein and LRRK2 that cause inherited forms of Parkinson’s disease.
Gray Laboratory
Michelle Gray, Ph.D., is an Associate Professor of Neurology. Her laboratory is focused broadly on uncovering the mechanisms that contribute to Huntington's disease pathogenesis.
Harms Laboratory
Ashley Harms, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of neuroinflammation in Parkinson disease and related disorders including multiple system atrophy.
Herskowitz Laboratory
Jeremy Herskowitz, Ph.D., is an Associate Professor of Neurology. His laboratory is focused on Alzheimer's disease and the development of novel therapeutic strategies to delay or prevent disease onset.
King Laboratory
Peter King, M.D., is a Professor of Neurology. His laboratory is focused on mechanisms of growth factor mRNA stabilization in malignant gliomas and amyotrophic lateral sclerosis (ALS).
Payami Laboratory
Haydeh Payami, Ph.D., is a Professor in Neurology. Her laboratory is focused on the prevention and treatment of Parkinson's disease and in particular the genes that interact with environmental risk factors. The goal is to predict who is at risk and what they should avoid and further personalize individual treatment for maximum benefit.
Roberson Laboratory
Erik Roberson, M.D., Ph.D., is a Professor of Neurology and Director of CNET. His laboratory focuses on Alzheimer's disease and frontotemporal dementia with an emphasis on tau, progranulin, and genetic risk factors for Alzheimer's.
Standaert Laboratory
David Standaert, M.D., Ph.D., is the Chairman and Professor of Neurology. His laboratory is focused on the pharmacology and neurochemistry of the basal ganglia and the mechanisms of Parkinson's disease and other conditions which produce abnormalities of movement.
Volpicelli-Daley Laboratory
Laura Volpicelli-Daley, Ph.D., is an Associate Professor of Neurology. Her laboratory is focused on determining how α-synuclein pathology found in Parkinson's disease and Dementia with Lewy Bodies impacts membrane traffic in neurons, as well as how genes implicated in Parkinson's disease impact α-synuclein pathology.
Yacoubian Laboratory
Talene Yacoubian, M.D., Ph.D., is a Professor of Neurology. Her laboratory is focused on understanding the pathophysiology of Parkinson’s disease with the long-term goal of developing neuroprotective therapies.